爱博特公司在Exact Sciences收购方面超过了2026年第一季度的每股利预期. Abbott beats Q1 2026 EPS estimates on Exact Sciences acquisition.

雅培报告了2026年第一季度的业绩,其调整后每股收益为1.15美元,销售额增长得益于对精确科学公司的收购. Abbott reported first-quarter 2026 results showing adjusted EPS of $1.15 and sales growth, driven by its acquisition of Exact Sciences. 该公司更新了2026年全年的预测,预计调整后的每股收益为5.38美元至5.58美元,可比销售增长率为6.5%至7.5%. The company updated its full-year 2026 guidance to expect adjusted EPS of $5.38 to $5.58 and comparable sales growth of 6.5% to 7.5%. 在宣布之后,阿博特股价在市场前交易中下跌了4.3%. Following the announcement, Abbott shares fell 4.3% in pre-market trading.